[Skip to Content]
[Skip to Content Landing]
Views 794
Citations 0
Research Letter
April 30, 2020

Association of Behavioral Nudges With High-Value Evidence-Based Prescribing in Oncology

Author Affiliations
  • 1Division of Hematology & Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia
  • 2Division of General Internal Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia
  • 3Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia
  • 4Lancaster General Health, Penn Medicine, Lancaster, Pennsylvania
  • 5Departments of Psychiatry and Medical Ethics & Health Policy, Perelman School of Medicine, University of Pennsylvania, Philadelphia
  • 6Penn Center for Cancer Care Innovation, Abramson Cancer Center, University of Pennsylvania, Philadelphia
JAMA Oncol. Published online April 30, 2020. doi:10.1001/jamaoncol.2020.0746

Identifying effective strategies to promote high-value, evidence-based prescribing is critical in oncology, where spending is projected to surpass $150 billion in 2020, driven in large part by cancer drugs.1 By intentionally modifying the way choices are framed, behavioral nudges can lead to desirable changes in prescribing while preserving clinician choice, and have been used effectively in primary care settings.2 It is unknown whether nudges can also influence specialty drug prescribing, where financial incentives often favor more expensive therapies.3

Limit 200 characters
Limit 25 characters
Conflicts of Interest Disclosure

Identify all potential conflicts of interest that might be relevant to your comment.

Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.

Err on the side of full disclosure.

If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.

Not all submitted comments are published. Please see our commenting policy for details.

Limit 140 characters
Limit 3600 characters or approximately 600 words
    ×